Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group.
Lebranchu
Y
Y
Service de Nephrologie, CHU Bretonneau, Tours, France.
Aubert
P
P
Bayle
F
F
Bedrossian
J
J
Berthoux
F
F
Bourbigot
B
B
Buchler
M
M
Chalopin
J M
JM
Deteix
P
P
Glotz
D
D
Huraut De Ligny
B
B
Kessler
M
M
Lang
P
P
Lefrancois
N
N
Le Pogamp
P
P
Moulin
B
B
Mourad
G
G
Olmer
M
M
Sraer
J D
JD
Touchard
G
G
Toupance
O
O
Wolf
P
P
Puget
S
S
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid